Eiry Roberts - Chief Medical Officer, Neurocrine Biosciences Inc
As of February 9, 2022
Eiry Roberts Net Worth
- Net worth is estimated to be at least $4.01M
- Owns at least 24,625 units of Neurocrine Biosciences Inc stock
- Sold an estimated value of $3M in the last 4 years at Neurocrine Biosciences Inc
Eiry Roberts Compensation at Neurocrine Biosciences Inc in 2018
- Earned a $490,700 salary and a $220 bonus
- Rewarded $4,053,869 in stock value and options
- Received a total compensation of $8,300,623
Eiry Roberts Trading
- Largest purchase of shares was 5,000 units , worth over $389.05K on June 25, 2020
- Largest sale of shares was 5,000 units , worth over $650K on June 25, 2020
- In total has made about 16 transactions over 4 years
- Usually trades in February, with the busiest year in 2020
EIRY ROBERTS
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Eiry Roberts Mailing Address
- Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Dieo CA 92130 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
| Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
| Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
| Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
| Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
| Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
| Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
| Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
| Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
| Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
| Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
| Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
| Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
| Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
| Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
Neurocrine Biosciences Inc Insider Trading
- The most recent transaction was 15,000 units sold on May 11, 2022 by Richard Pops worth over $1.14M
- In the last 19 years, insiders at Neurocrine Biosciences Inc sold an estimated value of $350.93M and bought an estimated value of $59.47M
- The most active traders are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer
- Insider trading is most common in May, with the busiest year in 2017
NEUROCRINE BIOSCIENCES INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||